StonvexLoading…
StonvexStonvexStonvexCore line items from NCLH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.33B | $9.83B | $7.58B | $4.65B |
Operating Income | $232.94M | $1.56B | $1.37B | $624.78M |
Net Income | $104.67M | $423.25M | $408.99M | $-10.30M |
EPS (Diluted) | $0.23 | $0.92 | $0.87 | $-0.02 |
Total Assets | $23.79B | $22.54B | $22.21B | $21.60B |
Total Liabilities | $21.36B | $20.33B | $20.02B | $20.03B |
Cash & Equivalents | $185.05M | $209.89M | $166.80M | $184.01M |
Free Cash Flow OCF − CapEx | $-625.22M | $-1.17B | $-1.19B | $-464.79M |
Shares Outstanding | 459.10M | 455.26M | 455.25M | 446.81M |